Study update: Dial COVID - March 2021
24
March
2021
Output type
Research brief
Location
Uganda
Focus areas
COVID-19
Topics
COVID-19
Programme
Humanitarian Research
This study update shares preliminary results of an R2HC study, which aims to assess uptake and validate a mobile telephone surveillance and mitigation tool (“Dial-COVID”) in refugee settlements in Uganda. The study also aims to understand refugees’ COVID-19 knowledge, risk perceptions, and barriers/facilitators to prevention and control measure adoption. Research is led by University of Washington with Infectious Diseases Institute and other partners.
The key takeaways of these preliminary findings are:
- Dial-COVID is accessed by both refugees and Ugandan nationals (internally displaced and not) living within refugee settlements and outside refugee settlements.
- Through Dial-COVID, we can disseminate public health information to hard-to-reach populations including refugees living in different refugee settlements in all four regions of Uganda.
- 57% of participants calling in to Dial-COVID report symptoms or an exposure that could be consistent with COVID-19 disease.
No items found.
Attachments
Other resources
explore all resources
Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015
‘Ebola is a business’: an analysis of the atmosphere of mistrust in the tenth Ebola epidemic in the DRC
Research Snapshot: The experiences of IDPs in Mali during COVID-19